Merck KGaA (MKKGY)
31.06
+0.28
(+0.91%)
USD |
OTCM |
Oct 09, 16:00
Merck Price : 31.06 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 30.90 | 31.11 | 30.87 | 31.06 | 136237.0 |
| Oct 08, 2026 | 30.91 | 30.92 | 30.39 | 30.78 | 113277.0 |
| Oct 07, 2026 | 31.32 | 31.50 | 30.99 | 31.37 | 70517.00 |
| Oct 06, 2026 | 31.93 | 31.93 | 31.10 | 31.25 | 183806.0 |
| Oct 05, 2026 | 30.48 | 30.71 | 30.38 | 30.69 | 106559.0 |
| Oct 02, 2026 | 30.61 | 30.89 | 30.55 | 30.87 | 105355.0 |
| Oct 01, 2026 | 30.79 | 30.79 | 30.05 | 30.11 | 90014.00 |
| Sep 30, 2026 | 31.29 | 31.57 | 31.11 | 31.11 | 42418.00 |
| Sep 29, 2026 | 31.31 | 31.34 | 31.02 | 31.31 | 69740.00 |
| Sep 28, 2026 | 31.30 | 31.70 | 31.29 | 31.66 | 55276.00 |
| Sep 25, 2026 | 30.98 | 30.98 | 30.70 | 30.86 | 36187.00 |
| Sep 24, 2026 | 30.41 | 30.78 | 30.41 | 30.64 | 73288.00 |
| Sep 23, 2026 | 30.33 | 30.37 | 30.09 | 30.15 | 37634.00 |
| Sep 22, 2026 | 30.43 | 30.74 | 30.30 | 30.46 | 79481.00 |
| Sep 21, 2026 | 30.27 | 30.48 | 30.17 | 30.39 | 50421.00 |
| Sep 18, 2026 | 30.01 | 30.01 | 29.65 | 29.75 | 103449.0 |
| Sep 17, 2026 | 30.27 | 30.49 | 30.04 | 30.14 | 141644.0 |
| Sep 16, 2026 | 30.39 | 30.54 | 30.07 | 30.13 | 41145.00 |
| Sep 15, 2026 | 29.96 | 30.37 | 29.87 | 30.16 | 166620.0 |
| Sep 14, 2026 | 30.85 | 30.85 | 29.90 | 30.09 | 1.529M |
| Sep 11, 2026 | 30.63 | 30.63 | 30.44 | 30.46 | 51395.00 |
| Sep 10, 2026 | 30.50 | 30.72 | 30.48 | 30.49 | 56337.00 |
| Sep 09, 2026 | 30.80 | 31.09 | 30.77 | 30.86 | 38430.00 |
| Sep 08, 2026 | 31.58 | 31.61 | 31.18 | 31.18 | 40261.00 |
| Sep 04, 2026 | 31.48 | 31.83 | 31.47 | 31.51 | 25149.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| STRATEC SE | 148.00 |
| Sartorius AG | 57.56 |
| Petros Pharmaceuticals, Inc. | 0.0034 |
| Agilent Technologies, Inc. | 170.54 |
| Bio-Rad Laboratories, Inc. | 366.16 |
Price Related Metrics
| PE Ratio | 24.41 |
| PS Ratio | 2.739 |
| Price to Book Value | 1.957 |
| Price to Free Cash Flow | 1734.29 |
| Earnings Yield | 4.10% |
| Market Cap | 20.07B |
| Operating PE Ratio | 13.92 |
| Normalized PE Ratio | 20.70 |